Pharmacia TNF-Inhibitor’s Monthly Dosing Could Offer Marketing Advantage
Pharmacia's experimental tumor necrosis factor inhibitor CDP-870 could gain a competitive advantage through a once-monthly dosing schedule
Pharmacia's experimental tumor necrosis factor inhibitor CDP-870 could gain a competitive advantage through a once-monthly dosing schedule